Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-11

FDA Approved: TESTOSTERONE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a generic testosterone product from Actavis Pharma (ANDA205328).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

SUPPL AP for TESTOSTERONE (TESTOSTERONE)